Photoacoustic Imaging Systems for Biomedical Engineers: Principles, Components, Clinical Applications, and Emerging Innovations

Photoacoustic imaging (PAI) has emerged as one of the most compelling hybrid modalities in the biomedical imaging landscape, combining the high optical contrast of laser-based excitation with the spatial resolution and penetration depth characteristic of ultrasound detection. For biomedical engineers working in medical device development, clinical instrumentation, or translational research, understanding the underlying physics, system architecture, and clinical applications of photoacoustic imaging systems is increasingly essential. This article provides a structured technical overview — from fundamental principles to component-level design — aimed squarely at practitioners who need more than a surface-level description of how these systems operate and why they matter within the broader ecosystem of medical imaging devices.

1. What is a Photoacoustic Imaging System?

A photoacoustic imaging system is a hybrid biomedical imaging modality that exploits the photoacoustic effect to generate high-contrast, high-resolution images of biological tissue. The photoacoustic effect itself is not a modern discovery — Alexander Graham Bell first described the phenomenon in 1880, when he observed that materials exposed to rapidly interrupted light produced audible sounds. However, it was not until advances in pulsed laser technology, sensitive ultrasound transducers, and digital signal processing made rapid clinical translation feasible that photoacoustic imaging emerged as a practical diagnostic tool. The UCL Photoacoustic Imaging Group, founded in 2003, played a pivotal role in advancing the clinical and scientific framework around which modern systems are built.

In contemporary biomedical engineering terms, a photoacoustic imaging system operates by directing short pulses of laser light — typically in the visible to near-infrared (NIR) range of 700–900 nm — into biological tissue. Endogenous chromophores such as oxyhemoglobin, deoxyhemoglobin, and melanin absorb this optical energy and undergo rapid thermoelastic expansion, generating broadband ultrasonic waves. These pressure waves propagate through the tissue and are detected by an array of ultrasound transducers placed at or near the tissue surface. Signal processing and image reconstruction algorithms then convert the acoustic data into spatially resolved maps of optical absorption, producing images that reflect the tissue’s biochemical and structural composition with a fidelity that neither pure optical imaging nor conventional ultrasound alone can achieve.

Regulatory Classification and Standards

From a regulatory standpoint, photoacoustic imaging systems are generally classified as FDA Class II medical devices, subject to 510(k) premarket notification pathways. Manufacturing quality management aligns with ISO 13485, while laser safety compliance falls under IEC 60601-2-33 and relevant ANSI Z136 standards. Engineers involved in device development must simultaneously address electromagnetic compatibility, laser safety classifications, and acoustic output limitations — a cross-disciplinary regulatory challenge unique to this hybrid modality.

2. Why is Photoacoustic Imaging Used?

Photoacoustic imaging occupies a distinctive niche within the broader medical imaging ecosystem because it resolves a fundamental limitation that has long constrained purely optical techniques: the optical diffusion barrier. In biological tissue, photons scatter strongly beyond depths of approximately 1 mm, severely limiting the spatial resolution and penetration of modalities like diffuse optical tomography or fluorescence imaging. Photoacoustic imaging circumvents this barrier by converting the absorbed optical energy into acoustic waves, which scatter orders of magnitude less than light in tissue. The result is a modality capable of resolving optical absorption contrast at depths of several centimeters — a capability that no purely optical method can match without sacrificing resolution.

Compared to anatomical imaging modalities such as CT scanners or nuclear techniques like SPECT, photoacoustic imaging offers intrinsic functional contrast without ionizing radiation or exogenous radiotracers. Hemoglobin, the primary oxygen-carrying molecule in blood, is among the strongest near-infrared absorbers in biological tissue, making PAI uniquely suited for vascular imaging and blood oxygen saturation (sO₂) mapping at the microscopic scale. This functional imaging capability has profound implications for oncology, where tumor angiogenesis and hypoxia are critical biomarkers, and for neuroscience, where cerebral hemodynamic monitoring at high resolution is a long-standing research goal.

Key Clinical Applications

Clinically and preclinically, photoacoustic imaging systems have demonstrated value across a range of applications. Breast cancer imaging benefits from the modality’s ability to detect the hypervascularity associated with malignant tumors without radiation exposure. Skin lesion characterization — particularly for melanoma, where melanin provides strong intrinsic contrast — is another area of active clinical evaluation. In the gastrointestinal space, endoscopic photoacoustic imaging has been explored for colon cancer detection. Beyond oncology, drug delivery monitoring using exogenous contrast agents, lymph node mapping with nanoparticle probes, and real-time monitoring of thermal therapy are established research applications. For biomedical engineers, this breadth of use cases translates into diverse system design requirements, from miniaturized endoscopic probes to large-format tomographic scanners.

3. How Does a Photoacoustic Imaging System Work?

The operational principle of a photoacoustic imaging system can be described in four sequential physical stages: optical absorption, thermoelastic expansion, acoustic wave propagation, and signal detection with image reconstruction. Understanding each stage at a quantitative level is fundamental for engineers involved in system design, performance optimization, or troubleshooting.

Stage 1 – Optical Absorption and Stress Confinement

A pulsed laser delivers nanosecond-duration light pulses — typically in the range of 5 to 10 ns — into the tissue. The pulse duration must satisfy the condition of stress confinement, meaning the acoustic transit time across the absorbing volume must be longer than the laser pulse duration. When a chromophore absorbs a photon, its internal energy increases rapidly. The absorbed fluence (J/cm²) and the tissue’s optical absorption coefficient (μₐ) together determine the local absorbed energy density. The Grüneisen parameter (Γ), a dimensionless thermodynamic quantity characterizing the efficiency of thermoelastic pressure generation, scales the conversion from absorbed energy to initial acoustic pressure. For blood, Γ is approximately 0.2–0.3 at physiological temperatures, meaning roughly 20–30% of absorbed optical energy is converted to mechanical stress.

Stage 2 – Acoustic Wave Generation and Propagation

The rapid thermoelastic expansion of absorbing structures generates broadband acoustic waves that propagate outward in all directions at the speed of sound in tissue — approximately 1,540 m/s in soft tissue. These waves are mechanical pressure perturbations, typically in the MHz frequency range, and carry spatial information about the distribution of optical absorbers within the tissue volume. Unlike ionizing radiation used in CT imaging, these acoustic waves interact minimally with soft tissue at diagnostic intensities, enabling relatively deep penetration with low signal attenuation.

Stage 3 – Signal Detection and Image Reconstruction

Piezoelectric or capacitive micromachined ultrasonic transducer (CMUT) arrays positioned at the tissue surface detect the time-resolved pressure signals. Each transducer element records a time-domain signal (A-line) corresponding to the arrival of acoustic waves from different depths. Multi-element array geometry and the time-of-flight information embedded in these signals enable spatial reconstruction of the original optical absorption distribution. Common reconstruction algorithms include delay-and-sum (DAS) beamforming, back-projection methods analogous to those used in CT reconstruction, and model-based iterative approaches that can incorporate acoustic heterogeneity corrections. Multi-wavelength illumination enables spectroscopic unmixing of chromophore contributions, yielding quantitative maps of oxyhemoglobin, deoxyhemoglobin, and blood oxygen saturation.

4. What Are the Main Components of a Photoacoustic Imaging System?

A photoacoustic imaging system integrates optical, acoustic, electronic, and computational subsystems into a unified platform. Each subsystem presents distinct engineering challenges, and the overall system performance is a product of how well these components are matched to one another in terms of frequency bandwidth, timing synchronization, and signal dynamic range.

Pulsed Laser Source

The laser is arguably the most critical and most expensive component of the system. Most research-grade and commercial systems employ Q-switched Nd:YAG lasers pumping optical parametric oscillators (OPOs), which enable wavelength tuning across the 680–950 nm NIR window. Pulse energies of 1–100 mJ/pulse at repetition rates of 10–50 Hz are typical for tomographic systems. Miniaturized systems increasingly use diode-pumped solid-state (DPSS) lasers or fiber-coupled laser diodes operating at fixed wavelengths to reduce cost and system footprint. Wavelength selection is governed by the absorption spectra of the target chromophores — 760 nm and 850 nm are commonly used dual wavelengths for separating oxyhemoglobin and deoxyhemoglobin contributions.

Light Delivery and Beam Conditioning Optics

Optical fiber bundles, articulated mirror arms, or free-space beam delivery systems guide the laser output to the tissue surface. Uniform illumination of the target region is essential to avoid fluence heterogeneity artifacts in reconstructed images. Beam expanders, diffusers, and custom fiber bundle geometries are engineered to maximize coverage while maintaining compliance with ANSI maximum permissible exposure (MPE) limits at the tissue surface — typically around 20 mJ/cm² in the NIR range.

Ultrasound Transducer Array

Linear, curved, or ring-array ultrasound transducers operating in the 5–50 MHz frequency range detect the photoacoustic signals. Higher center frequencies provide improved axial resolution but at the cost of penetration depth, following the same acoustic physics that govern conventional diagnostic ultrasound systems. CMUT technology offers broader bandwidth and easier integration with silicon fabrication processes compared to traditional PZT ceramics, and is increasingly adopted in research prototypes targeting combined PA-ultrasound functionality. Array geometry — whether linear, spherical, or full-ring — significantly influences the angular coverage of acoustic detection and therefore the image quality and artifact profile.

Data Acquisition and Signal Processing Electronics

High-speed analog-to-digital converters (ADCs) sampling at 40–250 MS/s with 12–16 bit resolution capture the low-amplitude photoacoustic signals simultaneously across all transducer channels. Low-noise amplification (LNA) stages immediately following the transducer elements are critical to achieving adequate signal-to-noise ratios, given that photoacoustic signal amplitudes at depth can be in the microvolt range. FPGA-based real-time processing pipelines handle beamforming, filtering, and preliminary image reconstruction, while host computing systems running custom or GPU-accelerated reconstruction software generate the final images. Timing synchronization between the laser Q-switch trigger and the data acquisition system must be maintained to sub-nanosecond precision to preserve axial resolution.

Image Reconstruction and Display Software

Software platforms handle spectral unmixing for functional imaging, motion correction, co-registration with co-acquired ultrasound B-mode images, and 3D volumetric rendering. Commercial platforms such as FUJIFILM VisualSonics Vevo LAZR and iThera Medical’s MSOT systems integrate proprietary reconstruction algorithms optimized for their specific hardware geometries, while open-source frameworks such as k-Wave (MATLAB/C++) are widely used in academic research for developing and validating custom reconstruction approaches.

5. What Types and Variants of Photoacoustic Imaging Systems Exist?

Photoacoustic imaging is not a monolithic technology — it encompasses a family of system architectures distinguished primarily by their spatial resolution, imaging depth, scanning geometry, and intended application context. Biomedical engineers selecting or designing PAI systems must understand the engineering trade-offs embedded in each variant, as the choice of architecture profoundly influences achievable performance parameters and clinical utility.

Photoacoustic Tomography (PAT)

Photoacoustic tomography systems use wide-field illumination to excite a large tissue volume and employ multi-element transducer arrays — often in ring or hemispherical configurations — to capture the resulting acoustic wavefield from multiple angles. Reconstruction algorithms analogous to those in CT scanners or SPECT systems recover 3D maps of optical absorption. PAT systems can image to depths of 5–7 cm with spatial resolutions in the range of 0.5–1 mm, making them suitable for whole-organ small-animal imaging (MSOT systems) and clinical breast imaging applications.

Photoacoustic Microscopy (PAM)

Photoacoustic microscopy achieves the highest spatial resolutions within the PAI family by using tightly focused optical beams (optical-resolution PAM, OR-PAM) or focused acoustic detection (acoustic-resolution PAM, AR-PAM). OR-PAM achieves lateral resolutions below 5 μm but is limited to superficial depths within the optical diffusion limit (~1 mm). AR-PAM trades lateral resolution (~45 μm) for improved depth penetration (~3–5 mm) by focusing the ultrasound detection rather than the excitation beam. PAM systems are particularly powerful for microvascular imaging, melanoma characterization, and single-cell imaging studies.

Hybrid Photoacoustic-Ultrasound Systems (PAUS)

Hybrid systems integrate photoacoustic and conventional B-mode ultrasound capabilities within a single probe platform, enabling simultaneous acquisition of functional optical-contrast PA images and structural acoustic images. The FUJIFILM VisualSonics Vevo LAZR-X is a prominent commercial example. This co-registration is clinically valuable because ultrasound provides anatomical context for interpreting PA functional data, and the combined modality reduces the need for separate imaging sessions. From an engineering standpoint, PAUS systems require careful management of laser interference with the ultrasound electronics and precise co-alignment of the optical and acoustic focal zones.

Functional Photoacoustic Imaging (fPAI)

Functional PAI refers to multi-spectral acquisition protocols applied to PAT or PAM platforms rather than a distinct hardware category. By illuminating tissue at multiple NIR wavelengths and applying spectral unmixing algorithms, fPAI generates quantitative maps of blood oxygen saturation, total hemoglobin concentration, and the distribution of exogenous contrast agents such as gold nanoparticles or organic dyes. This functional capability distinguishes PAI from purely anatomical modalities and positions it as a direct competitor to nuclear medicine techniques like SPECT for certain metabolic imaging applications — without the use of radioactive tracers.

6. What Are the Main Benefits of Photoacoustic Imaging?

Photoacoustic (PA) imaging occupies a uniquely advantageous position among modern biomedical imaging modalities, combining the molecular specificity of optical techniques with the spatial resolution and penetration depth of ultrasound imaging. For biomedical engineers evaluating imaging solutions, understanding these advantages is critical to identifying the right clinical application and system architecture.

Non-Ionizing, Non-Invasive Modality

Unlike CT scanners, which rely on ionizing X-ray radiation, photoacoustic systems use pulsed near-infrared (NIR) laser light that carries no ionizing risk to patients or operators. This makes PA imaging particularly attractive for longitudinal studies, pediatric applications, and scenarios where repeated imaging is required over extended periods.

Superior Optical Contrast with Ultrasound-Level Resolution

PA imaging achieves optical contrast at depths far beyond the reach of pure optical methods such as optical coherence tomography (OCT), which is typically limited to 1–2 mm of tissue penetration. By leveraging acoustic detection, PA systems can image optical absorbers at depths of 2–5 cm with spatial resolutions in the range of 100–500 µm, depending on system configuration. This hybrid contrast mechanism is unmatched by any single-modality system.

Functional and Molecular Imaging Capabilities

One of the most compelling advantages of PA imaging is its ability to perform real-time functional imaging without exogenous contrast agents. Hemoglobin — both oxygenated (HbO₂) and deoxygenated (Hb) — exhibits distinct optical absorption spectra. By illuminating tissue at multiple wavelengths and applying spectral unmixing algorithms, PA systems can generate quantitative maps of blood oxygen saturation (sO₂), enabling assessment of tissue hypoxia, tumor microenvironments, and vascular physiology. This capability supports applications ranging from breast cancer screening to monitoring therapeutic response in oncology.

Scalable Resolution-Depth Tradeoff

PA system design is inherently scalable. High-frequency transducers provide microscopic resolution suitable for preclinical small-animal imaging, while lower-frequency arrays extend imaging depth for clinical use. This scalability gives biomedical engineers significant flexibility in adapting PA platforms for diverse diagnostic needs, from intravascular imaging to whole-breast tomography.

7. What Are General Risks or Limitations?

Despite its considerable promise, photoacoustic imaging presents several engineering and clinical challenges that biomedical engineers must carefully consider during system design, regulatory submission, and clinical integration.

Limited Penetration Depth

Optical scattering in biological tissue fundamentally limits the depth at which usable PA signals can be generated. In practice, most PA systems achieve reliable imaging to approximately 2–5 cm, which constrains their utility for deep-tissue applications such as cardiac or abdominal imaging where conventional ultrasound remains superior. Engineers designing clinical PA systems must explicitly account for this trade-off in their intended-use specifications.

Laser Safety and Regulatory Compliance

PA systems rely on high-energy pulsed lasers, which introduce significant safety obligations. Compliance with IEC 60825-1 (laser product safety) and ANSI Z136.1 (safe use of lasers) is mandatory in most jurisdictions. Maximum permissible exposure (MPE) limits must be rigorously calculated for skin surface fluence, particularly in contact-based PA probes. Laser safety classification, interlock mechanisms, and operator training protocols are non-negotiable design elements that add engineering complexity and cost.

Acoustic Artifacts and Signal Complexity

Acoustic heterogeneity in tissue — variations in speed of sound, acoustic impedance, and attenuation — introduces reconstruction artifacts analogous to those seen in ultrasound imaging. Additionally, background PA signals from non-target chromophores, fluence attenuation with depth, and acoustic reverberation complicate quantitative interpretation. Robust image reconstruction algorithms and careful transducer selection are essential to mitigate these issues.

Cost, Complexity, and Limited Clinical Adoption

Current PA systems — particularly those incorporating tunable OPO lasers and high-density transducer arrays — carry significant capital costs and operational complexity. As of today, PA imaging is not yet a standard of care in most clinical settings, with regulatory clearances limited to specific applications such as breast imaging. Biomedical engineers pursuing clinical translation must factor reimbursement pathways, clinical workflow integration, and FDA 510(k) or De Novo submission strategies into their device development roadmaps.

8. How Is Photoacoustic Imaging Evolving? Recent Innovations

The PA imaging field is advancing rapidly across hardware, software, and clinical translation fronts. Engineers entering this space should be aware of the following developments that are reshaping the technology landscape.

AI-Powered Image Reconstruction

Deep learning models — including U-Net architectures and physics-informed neural networks — are being applied to PA image reconstruction, enabling faster, higher-quality image formation from sparse transducer data. These approaches reduce acquisition time and computational burden, making real-time 3D PA imaging increasingly feasible. This parallels trends in advanced ultrasound technologies, where AI reconstruction is also transforming image quality standards.

Wearable and Endoscopic PA Devices

Miniaturized fiber-optic light delivery and MEMS-based ultrasound detectors are enabling wearable PA patches for continuous hemodynamic monitoring and intravascular PA catheters for coronary plaque characterization. These form-factor innovations represent some of the most exciting engineering frontiers in the field.

Nanoparticle Contrast Agents and Clinical Translation

Engineered nanoparticle contrast agents — including gold nanorods and copper sulfide nanoparticles — are being developed to enhance PA signal at target tissues, improve molecular specificity, and enable targeted drug delivery monitoring. On the clinical translation front, the FDA-cleared Seno Imagio® system (Seno Medical) has demonstrated the viability of PA-ultrasound co-registration for breast lesion characterization, marking a significant milestone in the regulatory pathway for PA devices.

9. Key Takeaways and Tips for Biomedical Engineers

For biomedical engineers working on or evaluating photoacoustic imaging systems, the following guidance distills the most actionable technical and strategic considerations.

• Master laser safety requirements early. Incorporate IEC 60825-1 and ANSI Z136.1 compliance into your design from day one. Retrofitting laser safety controls late in development is costly and can delay regulatory submissions.
• Optimize wavelength selection for target chromophores. The diagnostic value of PA imaging depends critically on selecting illumination wavelengths that maximize contrast between the target absorber (e.g., HbO₂, lipids, melanin) and background tissue. Build a thorough understanding of tissue absorption spectra into your system design process.
• Balance resolution versus penetration depth in your system architecture. Define your clinical use case first, then select transducer frequency and laser parameters accordingly. A single PA platform cannot simultaneously optimize for microscopic resolution and deep-tissue penetration.
• Design for hybrid PA-ultrasound integration. Co-registered PA-US systems offer clinicians the familiarity of ultrasound alongside PA’s functional contrast, increasing clinical adoption potential and streamlining FDA regulatory strategy under existing ultrasound device frameworks.
• Stay current with AI reconstruction developments. Proficiency in deep learning-based image reconstruction is rapidly becoming a differentiating skill for biomedical engineers in the imaging space. Familiarize yourself with open-source PA toolkits such as k-Wave and emerging neural network reconstruction frameworks.
• Plan your regulatory pathway proactively. Engage with FDA early through pre-submission meetings. Understand whether your device qualifies for 510(k) clearance via a predicate PA or ultrasound device, or whether a De Novo pathway is required. ISO 13485 quality management system implementation should begin at project inception.

References

1. Wang, L. V., & Hu, S. (2012). Photoacoustic tomography: In vivo imaging from organelles to organs. Science, 335(6075), 1458–1462. https://doi.org/10.1126/science.1216210
2. Beard, P. (2011). Biomedical photoacoustic imaging. Interface Focus, 1(4), 602–631. https://doi.org/10.1098/rsfs.2011.0028
3. International Electrotechnical Commission. (2014). IEC 60825-1: Safety of laser products – Part 1: Equipment classification and requirements (Edition 3.0). IEC.
4. American National Standards Institute. (2014). ANSI Z136.1: American National Standard for Safe Use of Lasers. Laser Institute of America.
5. International Organization for Standardization. (2016). ISO 13485: Medical devices – Quality management systems – Requirements for regulatory purposes. ISO.
6. Valluru, K. S., & Bhatt, D. L. (2016). Molecular imaging of atherosclerosis with contrast-enhanced ultrasound and photoacoustic imaging. Circulation: Cardiovascular Imaging, 9(4), e003488. https://doi.org/10.1161/CIRCIMAGING.115.003488
7. Seno Medical Instruments. (2021). Imagio® Breast Imaging System – FDA 510(k) Cleared Device Overview. Seno Medical. Retrieved from https://www.senomedical.com
8. Treeby, B. E., & Cox, B. T. (2010). k-Wave: MATLAB toolbox for the simulation and reconstruction of photoacoustic wave fields. Journal of Biomedical Optics, 15(2), 021314. https://doi.org/10.1117/1.3360308